Finland· FI-REL-REL29289
Busol vet
A busereliini product containing buserelin acetate, registered in Finland by aniMedica GmbH. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Buserelin acetate is registered in 2 of 19 countries.
Countries holding a registration under ATC QH01CA90 (busereliini), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Buserelin acetate · ATC QH01CA90
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Buserelin acetate
- Manufacturer
- aniMedica GmbH
- Country
- Finland (FI)
- ATC code
- QH01CA90
- ATC class
- Busereliini
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Buserelin acetate in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBuserelin 5.5mg/5.5ml solution for injection vialsNeon Healthcare Ltd
- SwedenSuprecur 0,15 mg/dos Nässpray, lösningCheplapharm Arzneimittel GmbH
- ItalySUPREFACT*1 fiala SC 5,5 ml 1 mg/mlCHEPLAPHARM ARZNEIMITTEL GMBH
- SpainSUPREFACT 1 mg/ml SOLUCION INYECTABLECheplapharm Arzneimittel Gmbh
- GermanyMetrelefCheplapharm Arzneimittel Gmbh
- NetherlandsSuprefact Depot 3 maanden, implantatiestift 9,45 mgMedcor Pharmaceuticals B.V.
- CanadaSUPREFACTCHEPLAPHARM ARZNEIMITTEL GMBH
- BelgiumSuprefact Nasal 0.1 mgSanofi Belgium
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Suprecur, Suprefact
- Bulgaria · Супрефакт Депо 3 Месеца
- Germany · Profact Depot, Profact Pro Injectione
- Spain · Suprefact, Suprefact Depot
- United Kingdom (Northern Ireland) · Buserelin, Suprecur Injection
- Greece · Suprefact Depot 3 Μήνεσ
- Hungary · Suprefact
- Italy · Suprefact, Suprefact Depot
- Netherlands · Suprefact Depot
- Sweden · Suprecur, Suprefact
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/467166ff-9e25-4693-9edc-fdbfcedf9871 GET /v1/drugs/467166ff-9e25-4693-9edc-fdbfcedf9871?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, liuos",
"route": "Ihon alle",
"ddd_unit": null,
"strength": "0.004 mg/ml",
"atc_label": "Busereliini",
"ma_number": "23999",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL29289",
"authorised_at": "2009-03-04"
}See everything about buserelin acetate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.